0001214659-22-003836.txt : 20220309
0001214659-22-003836.hdr.sgml : 20220309
20220309182624
ACCESSION NUMBER: 0001214659-22-003836
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220307
FILED AS OF DATE: 20220309
DATE AS OF CHANGE: 20220309
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kazam Joshua A
CENTRAL INDEX KEY: 0001221355
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38693
FILM NUMBER: 22726748
MAIL ADDRESS:
STREET 1: 689 5TH AVENUE
STREET 2: 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
FORMER NAME:
FORMER CONFORMED NAME: KAZAM JOSHUA A
DATE OF NAME CHANGE: 20070920
FORMER NAME:
FORMER CONFORMED NAME: KAZAM JOSHOA A
DATE OF NAME CHANGE: 20030303
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allogene Therapeutics, Inc.
CENTRAL INDEX KEY: 0001737287
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 823562771
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 457-2700
MAIL ADDRESS:
STREET 1: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
marketforms-55743.xml
PRIMARY DOCUMENT
X0306
4
2022-03-07
0001737287
Allogene Therapeutics, Inc.
ALLO
0001221355
Kazam Joshua A
210 EAST GRAND AVENUE
SOUTH SAN FRANCISCO
CA
94080
true
false
false
false
Common Stock
2022-03-07
4
J
false
412618
0.0
A
671503
D
Common Stock
2022-03-07
4
G
false
412618
0.0
D
258885
D
The transactions reported in this form did not involve a purchase or sale of securities by the reporting person. On March 7, 2022, the reporting person acquired securities previously held in trust for the benefit of the reporting person arising from the termination of the trust. On the same day, the reporting person transferred the same securities to an irrevocable grantor trust having an independent trustee. The reporting person disclaims beneficial ownership of these shares except to the extent, if any, of the reporting person's pecuniary interest therein.
/s/ Veer Bhavnagri, Attorney-in-Fact
2022-03-09